A Trial Investigating the Influence of Oral Semaglutide on the Pharmacokinetics of Levothyroxine and the Influence of Co-administered Tablets on the Pharmacokinetics of Semaglutide Administered Orally in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 29 Jun 2017
At a glance
- Drugs Semaglutide (Primary) ; Levothyroxine sodium
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Novo Nordisk
- 26 Jun 2017 Status changed from active, no longer recruiting to completed.
- 29 Dec 2016 Status changed from recruiting to active, no longer recruiting.
- 14 Oct 2016 Status changed from not yet recruiting to recruiting.